Affinity Asset Advisors, LLC Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$746.0B
Holdings
83
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (83 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 750,000 | $67.5B | 9.05% | Put |
| 2 | XENEXENON PHARMACEUTICALS INC | 1,161,237 | $45.5B | 6.10% | |
| 3 | APGEAPOGEE THERAPEUTICS INC | 931,728 | $42.2B | 5.66% | |
| 4 | ACLXARCELLX INC | 425,000 | $32.6B | 4.37% | |
| 5 | ALKSALKERMES PLC | 1,100,000 | $31.6B | 4.24% | |
| 6 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $30.9B | 4.14% | |
| 7 | VRNAVERONA PHARMA PLC | 660,000 | $30.7B | 4.11% | |
| 8 | MDGLMADRIGAL PHARMACEUTICALS INC | 82,500 | $25.5B | 3.41% | |
| 9 | CRNXCRINETICS PHARMACEUTICALS IN | 460,000 | $23.5B | 3.15% | |
| 10 | NUVLNUVALENT INC | 285,000 | $22.3B | 2.99% | |
| 11 | SYRESPYRE THERAPEUTICS INC | 824,328 | $19.2B | 2.57% | |
| 12 | WVEWAVE LIFE SCIENCES LTD | 1,500,000 | $18.6B | 2.49% | |
| 13 | CNTACENTESSA PHARMACEUTICALS PLC | 1,095,924 | $18.4B | 2.46% | |
| 14 | VERAVERA THERAPEUTICS INC | 425,000 | $18.0B | 2.41% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 940,083 | $17.7B | 2.37% | |
| 16 | MESOMESOBLAST LTD | 838,600 | $16.6B | 2.23% | Put |
| 17 | MRUSMERUS N V | 389,241 | $16.4B | 2.19% | |
| 18 | —COHERUS BIOSCIENCES INC | 16,625,000 | $16.2B | 2.17% | |
| 19 | OMER 5.25 02/15/26OMEROS CORP | 15,525,000 | $14.6B | 1.96% | |
| 20 | ESTAESTABLISHMENT LABS HLDGS INC | 279,445 | $12.9B | 1.73% | |
| 21 | ARVNARVINAS INC | 630,000 | $12.1B | 1.62% | |
| 22 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 15,250,000 | $11.9B | 1.59% | |
| 23 | INZYINOZYME PHARMA INC | 3,972,318 | $11.0B | 1.47% | |
| 24 | NAMSNEWAMSTERDAM PHARMA COMPANY | 425,000 | $10.9B | 1.46% | |
| 25 | AUTLAUTOLUS THERAPEUTICS PLC | 4,500,000 | $10.6B | 1.42% | |
| 26 | GONGERON CORP | 2,250,000 | $8.0B | 1.07% | |
| 27 | AMGNAMGEN INC | 30,000 | $7.8B | 1.05% | Call |
| 28 | RZLTREZOLUTE INC | 1,575,000 | $7.7B | 1.03% | |
| 29 | PRQRPROQR THRAPEUTICS N V | 2,825,000 | $7.5B | 1.00% | |
| 30 | ORKAORUKA THERAPEUTICS INC | 368,698 | $7.1B | 0.96% | |
| 31 | AXSMAXSOME THERAPEUTICS INC | 75,000 | $6.3B | 0.85% | |
| 32 | ERASERASCA INC | 2,499,431 | $6.3B | 0.84% | |
| 33 | SLNOSOLENO THERAPEUTICS INC | 130,200 | $5.9B | 0.78% | Call |
| 34 | TVTX 2.25 03/01/29TRAVERE THERAPEUTICS INC | 6,000,000 | $5.7B | 0.77% | |
| 35 | ARWRARROWHEAD PHARMACEUTICALS IN | 300,000 | $5.6B | 0.76% | |
| 36 | BBIOBRIDGEBIO PHARMA INC | 200,000 | $5.5B | 0.74% | |
| 37 | NMRANEUMORA THERAPEUTICS INC. | 475,000 | $5.0B | 0.67% | Call |
| 38 | PTGXPROTAGONIST THERAPEUTICS INC | 130,000 | $5.0B | 0.67% | |
| 39 | MLYSMINERALYS THERAPEUTICS INC | 350,000 | $4.3B | 0.58% | |
| 40 | CATXPERSPECTIVE THERAPEUTICS INC | 1,300,000 | $4.1B | 0.56% | |
| 41 | SAVACASSAVA SCIENCES INC | 1,739,400 | $4.1B | 0.55% | Put |
| 42 | AVTXAVALO THERAPEUTICS INC | 550,765 | $4.1B | 0.55% | |
| 43 | —PERCEPTIVE CAP SOLUTIONS COR | 350,000 | $3.6B | 0.48% | |
| 44 | TVTXTRAVERE THERAPEUTICS INC | 200,000 | $3.5B | 0.47% | |
| 45 | IM8NINSMED INC | 50,000 | $3.5B | 0.46% | |
| 46 | NAMSNEWAMSTERDAM PHARMA COMPANY | 237,935 | $3.3B | 0.45% | |
| 47 | CMPSCOMPASS PATHWAYS PLC | 850,512 | $3.2B | 0.43% | |
| 48 | PHPNGALECTIN THERAPEUTICS INC | 2,492,000 | $3.2B | 0.43% | Put |
| 49 | CGEMCULLINAN THERAPEUTICS INC | 263,817 | $3.2B | 0.43% | |
| 50 | VRDNVIRIDIAN THERAPEUTICS INC | 159,614 | $3.1B | 0.41% | |
| 51 | MIRMMIRUM PHARMACEUTICALS INC | 70,742 | $2.9B | 0.39% | |
| 52 | CGONCG ONCOLOGY INC | 100,000 | $2.9B | 0.38% | |
| 53 | TECXTECTONIC THERAPEUTIC INC | 58,331 | $2.7B | 0.36% | |
| 54 | HLXCHELIX ACQUISITION CORP II | 250,000 | $2.6B | 0.35% | |
| 55 | OACCOAKTREE ACQUISITION CORP III | 250,000 | $2.5B | 0.34% | |
| 56 | IMVTIMMUNOVANT INC | 100,000 | $2.5B | 0.33% | |
| 57 | AVTEAEROVATE THERAPEUTICS INC | 800,000 | $2.1B | 0.28% | |
| 58 | PCVXVAXCYTE INC | 25,000 | $2.0B | 0.27% | |
| 59 | NKTXNKARTA INC | 800,000 | $2.0B | 0.27% | |
| 60 | NXTCNEXTCURE INC | 2,302,598 | $1.8B | 0.24% | |
| 61 | AVRANTERIS TECHNOLOGIES GLOBAL | 300,000 | $1.7B | 0.22% | |
| 62 | KYMRKYMERA THERAPEUTICS INC | 40,000 | $1.6B | 0.22% | |
| 63 | APLSAPELLIS PHARMACEUTICALS INC | 50,000 | $1.6B | 0.21% | |
| 64 | RAPTEURRAPT THERAPEUTICS INC | 1,000,000 | $1.6B | 0.21% | |
| 65 | NARIUSDINARI MED INC | 25,000 | $1.3B | 0.17% | |
| 66 | YB4PSAVARA INC | 410,586 | $1.3B | 0.17% | |
| 67 | OKURONKURE THERAPEUTICS INC | 144,159 | $1.2B | 0.17% | |
| 68 | BDTXBLACK DIAMOND THERAPEUTICS I | 559,163 | $1.2B | 0.16% | |
| 69 | CNTXCONTEXT THERAPEUTICS INC | 1,015,340 | $1.1B | 0.14% | |
| 70 | KZRKEZAR LIFE SCIENCES INC | 142,316 | $956.4M | 0.13% | |
| 71 | CLYMCLIMB BIO INC | 500,000 | $900.0M | 0.12% | |
| 72 | RADXRADIOPHARM THERANOSTICS LTD | 156,171 | $684.0M | 0.09% | |
| 73 | IBRXIMMUNITYBIO INC | 250,000 | $640.0M | 0.09% | Put |
| 74 | BMEABIOMEA FUSION INC | 150,000 | $582.0M | 0.08% | Put |
| 75 | ZURAZURA BIO LTD | 223,335 | $558.3M | 0.07% | |
| 76 | SYRSSYROS PHARMACEUTICALS INC | 1,691,200 | $388.6M | 0.05% | Put |
| 77 | TCE2CELLDEX THERAPEUTICS INC NEW | 9,992 | $252.5M | 0.03% | |
| 78 | ADGMADAGIO MED HLDGS INC | 213,235 | $223.9M | 0.03% | |
| 79 | RPTXREPARE THERAPEUTICS INC | 100,000 | $131.0M | 0.02% | |
| 80 | OMEROMEROS CORP | 9,958 | $98.4M | 0.01% | |
| 81 | QTTBQ32 BIO INC | 27,777 | $95.6M | 0.01% | |
| 82 | IMTXIMMATICS N.V | 187,204 | $47.1M | 0.01% | |
| 83 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $2.6M | 0.00% |